About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalSoutheastern U.S.
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
342
By Phase
PHASE2: 4PHASE1: 1
By Status
COMPLETED: 4RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06440525Lead Sponsor
A Study of RSLV-132 in Females With Sjögren's Disease
PHASE2Recruiting
106 participants
Started: Dec 1, 2024 · Completed: Mar 1, 2027
NCT04944121Lead Sponsor
Phase 2 Study of RSLV-132 in Subjects With Long COVID
PHASE2Completed
112 participants
Started: Jun 25, 2021 · Completed: Nov 30, 2023
NCT03247686Lead Sponsor
A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome
PHASE2Completed
28 participants
Started: Feb 1, 2017 · Completed: Aug 1, 2019
NCT02660944Lead Sponsor
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
PHASE2Completed
64 participants
Started: Jan 3, 2016 · Completed: Aug 10, 2020
NCT02194400Lead Sponsor
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
PHASE1Completed
32 participants
Started: Jul 31, 2014 · Completed: Nov 30, 2015
Locations (1)
Headquarters
Miami, FL, United States
Map
Loading map...